A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gabapentine Impurity 41 - Request Quote

Picture of Gabapentine Impurity 41

Gabapentine Impurity 41

SZ CAT No:SZ-G001062
CAS No
NA
Mol.F.
C10H14NO3 : Na
Mol.Wt.
196.2 : 23.0
Inv. Status
Synthesis on demand
Rel. CAS No2505132-15-8 (free base)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Gabapentine Impurity 41 is chemically Sodium 2-(1-(isocyanatomethyl)cyclohexyl)acetate. Gabapentine Impurity 41 is supplied with detailed characterization data compliant with regulatory guideline. Gabapentine Impurity 41 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gabapentin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Gabapentine Impurity 41

Purchase Gabapentine Impurity 41

Gabapentine Impurity 41 suppliers

Gabapentine Impurity 41 manufacturers

Gabapentine Impurity 41 price

Order Gabapentine Impurity 41

Enquire Gabapentine Impurity 41

Gabapentine Impurity 41 cost

Gabapentine Impurity 41 Supplier

Gabapentine Impurity 41 Distributor

Gabapentine Impurity 41 for Method Validation

Gabapentin Reference Standard

Gabapentine Impurity 41 for ANDA Filing

Gabapentine Impurity 41 for Forced Degradation Studies

Gabapentine Impurity 41 Identification Standards

Gabapentine Impurity 41 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,